BREAKING
Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 hour ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 3 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 5 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 7 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 9 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 10 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 10 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 11 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 13 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 hour ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 3 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 5 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 7 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 9 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 10 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 10 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 11 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 13 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 13 hours ago
ADVERTISEMENT
Market News

Diebold (NYSE: DBD): Q3 2019 Earnings Snapshot

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected. — Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is […]

$DBD October 29, 2019 1 min read

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected.

— Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is hurting customer demand for Retail solutions.

Earnings Update by AlphaStreet

— Sales from Eurasia Banking declined by 7% while that from the Americas Banking increased by 6%. Total retail sales fell by 11%.

— Looking ahead into the full year 2019, the company lowered its total revenue outlook to about $4.4 billion from the previous estimate of about $4.5 billion.

ADVERTISEMENT

— Adjusted EBITDA is now expected to be in the range of $400 million to $410 million compared to the prior forecast range of $400 million to $420 million.

— Net cash provided by operating activities is now predicted to be in the $120 million to $150 million range, up from the earlier forecast of about $100 million.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT